Article info
PDFColon
Paper
Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer
- Correspondence to Polly A Newcomb, Head and Full Member, Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4-B402 Seattle, WA 98109, USA; pnewcomb{at}fhcrc.org
- Cornelia Ulrich, Director, National Center for Tumor Diseases (NCT), Division of Preventive Oncology, German Cancer Research Center, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany; neli.ulrich{at}nct-heidelberg.de
Citation
Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer
Publication history
- Revised September 22, 2010
- Accepted September 23, 2010
- First published November 4, 2010.
Online issue publication
March 04, 2011
Article Versions
- Previous version (4 November 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.